Metehan Keskin

Metehan Keskin

Auto-generated profile, based on publicly available information

Metehan Keskin

ONDOKUZ MAYIS ÜNİVERSİTESİ, DİŞ HEKİMLİĞİ FAKÜLTESİ

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Journal of Clinical and Diagnostic Research
Verified
Journal Article
Open access
MKMetehan Keskin
Metehan Keskin
NÖNilüfer ÖZKAN
Nilüfer ÖZKAN
NANihat Akbulut
Nihat Akbulut
MBMehmet Cihan Bereket
Mehmet Cihan Bereket
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.

2 June 2025 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
YKYonca Kanat
Yonca Kanat
MBMehmet Cihan Bereket
Mehmet Cihan Bereket
MOMehmet Emin Onger
Mehmet Emin Onger
NPNisa Nur Polat
Nisa Nur Polat
GAGamze Altun
Gamze Altun
APAhmet Veysel Polat
Ahmet Veysel Polat

22 August 2025 in Selcuk Dental Journal
Verified
Journal Article
Open access
PDF file
RÇRabia Tül Adeviye Çankaya
Rabia Tül Adeviye Çankaya
MKMetehan Keskin
Metehan Keskin
SGSeda Gün
Seda Gün
This article outlines the diagnosis and treatment of two cases presenting with concurrent dentigerous cysts (DC) and odontogenic keratocysts (OKC) with similar radiographic and clinical appearances that occur simultaneously in the mandible in patients without syndrome. Case 1: A 9-year-old female with hemophilia C exhibited swelling in the lower jaw's retromolar regions. Radiographic assessments revealed well-circumscribed radiolucent areas associated with teeth #37 and #47 on both sides. Marsupialization addressed the right OKC, while enucleation treated the left DC. Satisfactory healing occurred with better recovery in the DC. No recurrence was observed during the three-year follow-up. Case 2: A healthy 21-year-old male, previously diagnosed with jaw cysts, presented lesions around #38 and #48. Marsupialization and enucleation were performed on the right and left lesions, respectively. Pathological examination confirmed DC and OKC. OKC recurred after 2 years, necessitating re-operation.

1 December 2021 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
EYEzgi Yüceer-Çetiner
Ezgi Yüceer-Çetiner
NÖNilüfer Özkan
Nilüfer Özkan
MÖMehmet Emin Önger
Mehmet Emin Önger
MGMustafa Yavuz Gülbahar
Mustafa Yavuz Gülbahar
MKMetehan Keskin
Metehan Keskin

23 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
MKMetehan Keskin
Metehan Keskin
FAFurkan Aksoy
Furkan Aksoy
BackgroundOral DLBCL is the most common subtype of non-Hodgkin lymphoma in the head and neck region, yet primary involvement of the oral cavity is rare and frequently leads to diagnostic error. Due to its non-specific clinical and radiographic presentation, oral diffuse large B-cell lymphoma is often misdiagnosed, resulting in delayed biopsy and inappropriate initial management.MethodsThis article reviews reported cases of oral diffuse large B-cell lymphoma in which an initial misdiagnosis or diagnostic delay was documented, aiming to highlight common diagnostic challenges and clinical pitfalls. To illustrate these challenges, we present a representative case of a 42-year-old male with a maxillary lesion initially presumed to be inflammatory in origin.ResultsThe reviewed literature demonstrates that oral diffuse large B-cell lymphoma commonly mimics inflammatory oral conditions, particularly when presenting with swelling, tooth mobility or bone destruction. In presented case, histopathological and immunohistochemical examination confirmed DLBCL of germinal center B-cell-like subtype with a high Ki-67 proliferation index.ConclusionThis review emphasizes the importance of maintaining a high index of suspicion for malignancy in persistent or atypical oral lesions. Early histopathological evaluation is essential to prevent diagnostic delay and to improve clinical outcomes in patients with oral diffuse large B-cell lymphoma.